Clinical Trial Update: Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial exploring the combination of simvastatin and albumin-bound paclitaxel for extensive-stage small cell lung cancer (ES-SCLC) in patients relapsed af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN